pli@cooley.com
Pengli Li focuses her practice on mergers and acquisitions, emerging companies, venture capital transactions and capital markets, particularly in the software and life sciences industries.
Download full bio
Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp.
Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab
Repare Therapeutics - $253 Million IPO
Datadog – $745 Million IPO
Milestone Pharmaceuticals – $95 Million IPO
Mergers & Acquisitions
Emerging Companies
Venture Capital
Capital Markets
Cornell Law SchoolJD, 2016
The George Washington UniversityBA, Political Sciencesumma cum laude, 2013
Massachusetts
New York
Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp. August 17, 2021
Datadog – $745.2 Million IPO October 1, 2019
SoftBank Vision Fund Leads $400 Million Series C for Relay Therapeutics December 27, 2018
+1 617 937 2405
Locations